Evidence map›Paper›PMID 39417538›Full record

ArticleBalkan medical journal2024

Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-2: Specific Entities, Risk Stratification and Challenges After Recovery)

Kenan Yalta, John E Madias, Nicholas G Kounis, Shams Y-Hassan, Marija Polovina, Servet Altay, Alexandre Mebazaa, Mehmet Birhan Yilmaz, Yuri Lopatin, Mamas A Mamas and 13 more

Abstract readConsensus Statement
In one paragraph

Article in Balkan medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Kenan YaltaDepartment of Cardiology, Trakya University Faculty of Medicine, Edirne, TürkiyeORCID 0000-0001-5966-2488
John E MadiasDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, Elmhurst, NY, United States of America
Nicholas G KounisDepartment of Cardiology, University of Patras Medical School, Patras, GreeceORCID 0000-0002-9751-6710
Shams Y-HassanCoronary Artery Disease Area, Heart and Vascular Theme, Karolinska Institutet and Karolinska University Hospital, Stockholm, SwedenORCID 0000-0001-5228-9035
Marija PolovinaDepartment of Cardiology, University of Belgrade, University Clinical Centre of Serbia, Belgrade, SerbiaORCID 0000-0001-9589-0023
Servet AltayDepartment of Cardiology, Trakya University Faculty of Medicine, Edirne, TürkiyeORCID 0000-0001-7112-3970
Alexandre MebazaaUniversity Paris Cite, Department of Anesthesia-Burn-Critical Care, Université de Paris, UMR Inserm MASCOT; APHP Saint Louis Lariboisière University Hospitals, Paris, FranceORCID 0000-0001-8715-7753
Mehmet Birhan YilmazDepartment of Cardiology, Dokuz Eylül University Faculty of Medicine, İzmir, TürkiyeORCID 0000-0002-8169-8628
Yuri LopatinDepartment of Cardiology, Volgograd State Medical University, Regional Cardiology Centre, Volgograd, RussiaORCID 0000-0001-8744-7144
Mamas A MamasDepartment of Cardiology, Centre for Prognosis Research, Keele University, Stoke-on-Trent, United KingdomORCID 0000-0001-9241-8890
Robert J GilDepartment of Cardiology, National Medical Institute of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Ritu ThammanDepartment of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, United States of AmericaORCID 0000-0002-4661-0651
Abdallah AlmaghrabyDepartment of Cardiology, Ibrahim Bin Hamad Obaidallah Hospital, EHS, Ras Al Khaimah, United Arab EmiratesORCID 0000-0001-6541-0850
Biykem BozkurtDepartment of Cardiology, Baylor College of Medicine, Houston TX, United States of AmericaORCID 0000-0002-6362-0253
Gani BajraktariDepartment of Cardiology, University Clinical Centre of Kosova, Prishtina, KosovoORCID 0009-0006-9640-5652
Thomas FinkDepartment of Cardiology, Division of Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum, Bad Oeynhausen, GermanyORCID 0000-0002-6665-7326
Vassil TraykovDepartment of Cardiology, Division of Invasive Electrophysiology, Acıbadem City Clinic Tokuda University Hospital, Sofia, BulgariaORCID 0000-0002-9523-6416
Stephane Manzo-SilbermanDepartment of Cardiology, Pitié-Salpêtrière Hospital, Institute of Cardiology, ACTION Study Group, Sorbonne University, Paris, FranceORCID 0000-0002-0703-1331
Ulvi MirzoyevMedical Center of The Ministry of Emergency Situations of Azerbaijan; President of Azerbaijan Society of Cardiology, Baku, AzerbaijanORCID 0009-0009-0421-2581
Sekib SokolovicDepartment of Cardiology, Cardiology and Rheumatology Hospital, Sarajevo University Clinical Center, Sarajevo, Bosnia HerzegovinaORCID 0000-0001-6321-4186
Zviad V KipianiDepartment of Cardiology, New Hospital, Tbilisi, Georgia
Cecilia LindeDepartment of Cardiology, Karolinska Institutet, Stockholm, SwedenORCID 0000-0002-9039-6023
Petar M SeferovicDepartment of Cardiology, Serbian Academy of Sciences and Arts and Faculty of Medicine, University of Belgrade, Belgrade, SerbiaORCID 0000-0002-1955-4199

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takotsubo syndrome (TTS) still remains as an enigmatic phenomenon. In particular, long-term challenges (including clinical recurrence and persistent symptoms) and specific entities in the setting of TTS have been the evolving areas of interest. On the other hand, a significant gap still exists regarding the proper risk-stratification of this phenomenon in the short and long terms. The present paper, the second part (part-2) of the consensus report, aims to discuss less well-known aspects of TTS including specific entities, challenges after recovery and risk-stratification.

Indexed as

ConsensusTakotsubo CardiomyopathyHumansRisk Assessment

Identifiers

PMID39417538
PMCPMC11589209

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.